{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T10:40:39Z","timestamp":1777891239097,"version":"3.51.4"},"reference-count":19,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Subst\ufffdAbuse"],"published-print":{"date-parts":[[2014,1]]},"abstract":"<jats:p>\n                    Various studies have reported that abuse of cannabis is a risk factor for psychosis. The aims of this study were to determine the prevalence of delta 9-tetrahydrocanabinol (\u0394\n                    <jats:sup>9<\/jats:sup>\n                    -THC), a major metabolite of cannabis, in psychiatric patients in Uganda, and to assess the diagnostic capacity of two referral mental health hospitals to screen patients for exposure to cannabis in Uganda. Socio-demographic characteristics of the patients were collected through questionnaires and review of medical records. Urine samples were collected from 100 patients and analyzed using \u0394\n                    <jats:sup>9<\/jats:sup>\n                    -THC immunochromatographic kit (Standard Diagnostics\u00ae, South Korea). Seventeen percent of the patients tested positive for \u0394\n                    <jats:sup>9<\/jats:sup>\n                    -THC residues in their urine. There was strong association ( p &lt; 0.05) between history of previous abuse of cannabis and presence of \u0394\n                    <jats:sup>9<\/jats:sup>\n                    -THC residues in the urine. Alcohol, cocaine, heroin, pethidine, tobacco, khat and kuber were the other substances abused in various combinations. Both referral hospitals lacked laboratory diagnostic kits for detection of cannabis in psychiatric patients. In conclusion, previous abuse of cannabis is associated with occurrence of the residues in psychiatric patients, yet referral mental health facilities in Uganda do not have the appropriate diagnostic kits for detection of cannabis residues as a basis for evidence-based psychotherapy.\n                  <\/jats:p>","DOI":"10.4137\/sart.s13254","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T17:44:28Z","timestamp":1389203068000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Prevalence of Cannabis Residues in Psychiatric Patients: A Case Study of Two Mental Health Referral Hospitals in Uganda"],"prefix":"10.4137","volume":"8","author":[{"given":"Epaenetus A.","family":"Awuzu","sequence":"first","affiliation":[{"name":"Department of Veterinary Pharmacy, Clinics and Comparative Medicine; College of Veterinary Medicine, Animal Resources and Biosecurity-Makerere University, Kampala, Uganda."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Kaye","sequence":"additional","affiliation":[{"name":"Division of Toxicology, Directorate of Government Analytical Laboratory, Kampala, Uganda."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Vudriko","sequence":"additional","affiliation":[{"name":"Department of Veterinary Pharmacy, Clinics and Comparative Medicine; College of Veterinary Medicine, Animal Resources and Biosecurity-Makerere University, Kampala, Uganda."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2014,1,8]]},"reference":[{"key":"bibr1-SART.S13254","unstructured":"WHO. Mental Health. New understanding, New Hope. The World Health Report. World Health Organization. Geneva, 2001. Available at http:\/\/www.mentalhealthpromotion.net\/resources\/whr01_en-3.pdf. Accessed September 16, 2013."},{"key":"bibr2-SART.S13254","volume-title":"Psychiatry for primary health care in Uganda.","author":"Emilio O.","year":"2006","edition":"1"},{"key":"bibr3-SART.S13254","doi-asserted-by":"crossref","unstructured":"EliasB., ElizabethC., SamuelM., JeromeK. Pioneering work in mental health out-reaches in rural, South Western Uganda. 2008; 6(2): 117\u201331. Available at http:\/\/ourmediaourselves.com\/archives\/62pdf\/byaruhanga.pdf. Accessed September 14, 2013.","DOI":"10.1097\/WTF.0b013e328307ed56"},{"key":"bibr4-SART.S13254","author":"WHO.","year":"2005","journal-title":"Geneva, World Health Organization;"},{"key":"bibr5-SART.S13254","volume-title":"Cannabinoids.","author":"Vincenzo D.M.","year":"2004","edition":"1"},{"key":"bibr6-SART.S13254","volume-title":"World drug report","author":"UNODC.","year":"2009"},{"issue":"9","key":"bibr7-SART.S13254","first-page":"583","volume":"60","author":"Hubbard J.R.","year":"1999","journal-title":"Am Fam Phys."},{"key":"bibr8-SART.S13254","unstructured":"WHO. Neuroscience of Psychoactive Substance Use and Dependence: Summary. World Health Organization. Geneva, 2004. Available at http:\/\/www.who.int\/substance_abuse\/publications\/en\/Neuroscience_E.pdf. Accessed September 16, 2013."},{"key":"bibr9-SART.S13254","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.184.2.110"},{"key":"bibr10-SART.S13254","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.320.7227.108"},{"key":"bibr11-SART.S13254","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(95)00609-5"},{"key":"bibr12-SART.S13254","unstructured":"WendyK., JudyB. Drug abuse warning network. The DAWN report, 2003; 1\u20133. Available at http:\/\/www.oas.samhsa.gov\/MJ2k3ED.pdf. Accessed September 16, 2013."},{"key":"bibr13-SART.S13254","doi-asserted-by":"publisher","DOI":"10.1111\/j.1521-0391.1995.tb00257.x"},{"key":"bibr14-SART.S13254","volume-title":"Cannabinoids.","author":"Vincenzo D.M.","year":"2004","edition":"1"},{"key":"bibr15-SART.S13254","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.58.10.909"},{"key":"bibr16-SART.S13254","doi-asserted-by":"publisher","DOI":"10.1016\/S0377-1237(05)80004-8"},{"key":"bibr17-SART.S13254","author":"NIDA.","year":"2004","journal-title":"Bethesda, National Institute on Drug Abuse;"},{"key":"bibr18-SART.S13254","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwf043"},{"issue":"9","key":"bibr19-SART.S13254","first-page":"583","volume":"60","author":"Hubbard J.R.","year":"1999","journal-title":"Am Fam physician."}],"container-title":["Substance Abuse: Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.4137\/SART.S13254","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.4137\/SART.S13254","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.4137\/SART.S13254","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T05:57:58Z","timestamp":1777615078000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.4137\/SART.S13254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":19,"alternative-id":["10.4137\/SART.S13254"],"URL":"https:\/\/doi.org\/10.4137\/sart.s13254","relation":{},"ISSN":["1178-2218","1178-2218"],"issn-type":[{"value":"1178-2218","type":"print"},{"value":"1178-2218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1]]},"article-number":"SART.S13254"}}